n(6)-carboxymethyllysine has been researched along with Abnormality, Heart in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eriksson, UJ; Gittenberger-de Groot, AC; Molin, DG; Roest, PA; Schalkwijk, CG; van Iperen, L; Wentzel, P | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Abnormality, Heart
Article | Year |
---|---|
Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.
Topics: Animals; Congenital Abnormalities; Disease Models, Animal; Embryo, Mammalian; Female; Glycation End Products, Advanced; Heart Defects, Congenital; Humans; Infant, Newborn; Lysine; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Risk Factors; Smad2 Protein; Vascular Endothelial Growth Factor A; Wound Healing | 2009 |